Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European journal of medicinal chemistry

• Publication date

  2003-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0223-5234(03)00113-2PMID 12932897
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice

  2006cited by this paper
• LY404187: a novel positive allosteric modulator of AMPA receptors.

  2006cited by this paper
• Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics

  2005cited by this paper
• Glycine site antagonists abolish dopamine D 2 but not D 1 receptor mediated catalepsy in rats

  2005cited by this paper
• Arzneimittelforschung

  2005cited by this paper
• Novel glycineB antagonists show neuroprotective activityin vivo

  2005cited by this paper
• Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning

  2005cited by this paper
• Role of excitatory amino acid receptors in mono- and polysynaptic excitation in the cat spinal cord

  2004cited by this paper
• Thresholds and encoding of neuronal responses to mechanical stimuli in the ventro-basal thalamus during carrageenin-induced hyperalgesic inflammation in the rat

  2004cited by this paper
• SM-31900, a novel NMDA receptor glycine-binding site antagonist, reduces infarct volume induced by permanent middle cerebral artery occlusion in spontaneously hypertensive rats.

  2003cited by this paper
• Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.

  2003cited by this paper
• Efficacy of newer generation antipsychotics in the treatment of schizophrenia.

  2003cited by this paper
• Glutamatergic mechanisms in schizophrenia.

  2003cited by this paper
• Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia: Linkage disequilibrium mapping using SNPs evenly distributed across the gene region

  2003cited by this paper
• Restorative effects of glutamate antagonists in experimental parkinsonism

  2002cited by this paper
• COX-2 inhibition and the control of pain.

  2002cited by this paper
• Adaptation to chronic PCP results in hyperfunctional NMDA and hypofunctional GABA(A) synaptic receptors.

  2002cited by this paper
• Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).

  2002cited by this paper
• Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions

  2002cited by this paper
• Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits

  2002cited by this paper
• In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.

  2002cited by this paper
• D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia.

  2002cited by this paper
• Neuroprotective Activity of a Nanoparticulate Formulation of the GlycineB Site Antagonist MRZ 2/576 in Transient Focal Ischaemia in Rats

  2002cited by this paper
• Modulation of glutamate receptors: Strategies for the development of novel antidepressants

  2002cited by this paper
• Positive modulators of AMPA receptors as a potential treatment for schizophrenia.

  2002cited by this paper
• Selective agonists and antagonists for kainate receptors.

  2002cited by this paper
• Pharmacological Characterization of Ro 63-1908 (1-[2-(4-Hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a Novel Subtype-SelectiveN-Methyl-d-Aspartate Antagonist

  2002cited by this paper
• Management of negative symptoms of schizophrenia

  2001cited by this paper
• The NMDA receptor complex: a promising target for novel antiepileptic strategies.

  2001cited by this paper
• Cyclooxygenase inhibitors--current status and future prospects.

  2001cited by this paper
• Synthesis of Tricyclic Indole-2-caboxylic Acids as Potent NMDA-Glycine Antagonists

  2001cited by this paper
• Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.

  2001cited by this paper
• Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function

  2001cited by this paper
• The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.

  2001cited by this paper
• Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial.

  2001cited by this paper
• Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidines.

  2001cited by this paper
• A Calcium-Dependent Feedback Mechanism Participates in Shaping Single NMDA Miniature EPSCs

  2001cited by this paper
• Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation

  2001cited by this paper
• Adjunctive high-dose glycine in the treatment of schizophrenia.

  2001cited by this paper
• N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.

  2001cited by this paper
• GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice.

  2001cited by this paper
• NMDA receptor antagonists as analgesics: focus on the NR2B subtype.

  2001cited by this paper
• Synthesis of tricyclic indole-2-carboxylic [correction of caboxylic] acids as potent NMDA-glycine antagonists.

  2001cited by this paper
• Transient Expression of NMDA Receptor Subunit NR2B in the Developing Rat Heart

  2000cited by this paper
• Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test.

  2000cited by this paper
• Placebo-controlled trial of glycine added to clozapine in schizophrenia.

  2000cited by this paper
• Felbamate in Experimental Model of Status Epilepticus

  2000cited by this paper
• Complete Prevention but Stimulus-dependent Reversion of Morphine Tolerance by the Glycine/NMDA Receptor Antagonist (+)-HA966 in Neuropathic Rats

  2000cited by this paper
• Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways

  2000cited by this paper
• A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.

  2000cited by this paper
• Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus

  2000cited by this paper
• NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice.

  2000cited by this paper
• Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors.

  2000cited by this paper
• [Pathophysiology of pain].

  2000cited by this paper
• Glutamate and Kynurenate in the Rat Central Nervous System Following Treatments with Tail Ischaemia or Diclofenac

  2000cited by this paper
• Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study.

  2000cited by this paper
• Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs.

  2000cited by this paper
• Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.

  1999cited by this paper
• GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist.

  1999cited by this paper
• Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes.

  1999cited by this paper
• Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain.

  1999cited by this paper
• ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.

  1999cited by this paper
• D-serine added to clozapine for the treatment of schizophrenia.

  1999cited by this paper
• Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke.

  1999cited by this paper
• Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.

  1999cited by this paper
• A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia.

  1999cited by this paper
• Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.

  1999cited by this paper
• N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat.

  1999cited by this paper
• Neuroactive Amino Acids in Focally Epileptic Human Brain: A Review

  1999cited by this paper
• Effects of Intrathecal NMDA and Non-NMDA Antagonists on Acute Thermal Nociception and Their Interaction with Morphine

  1998cited by this paper
• Strychnine-insensitive glycine/NMDA sites are altered in two stress models of depression.

  1998cited by this paper
• D-serine added to antipsychotics for the treatment of schizophrenia.

  1998cited by this paper
• ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.

  1998cited by this paper
• Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A

  1998cited by this paper
• A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.

  1998cited by this paper
• Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice.

  1998cited by this paper
• IDENTIFICATION AND PHARMACOLOGICAL CHARACTERIZATION OF GV150526, A NOVEL GLYCINE ANTAGONIST AS A POTENT NEUROPROTECTIVE AGENT

  1998cited by this paper
• Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-D-aspartate receptor.

  1998cited by this paper
• Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions.

  1997cited by this paper
• Antinociceptive activity of CP‐101,606, an NMDA receptor NR2B subunit antagonist

  1997cited by this paper
• Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.

  1997cited by this paper
• Antinociceptive effects of NMDA and non‐NMDA receptor antagonists in the tail flick test in mice

  1997cited by this paper
• Am J Psychiatry

  1996cited by this paper
• Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase.

  1996cited by this paper
• Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia.

  1996cited by this paper
• Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice.

  1996cited by this paper
• The pharmacology and mechanism of action of riluzole

  1996cited by this paper
• Amyloid β Peptide (25–35) Inhibits Na+‐Dependent Glutamate Uptake in Rat Hippocampal Astrocyte Cultures

  1996cited by this paper
• Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.

  1996cited by this paper
• d-Cycloserine enhances implicit memory in Alzheimer patients

  1996cited by this paper
• Excitotoxicity in ALS

  1996cited by this paper
• Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation‐induced mechanical hyperalgesia in rats

  1996cited by this paper
• β‐Amyloid peptide fragment 25–35 potentiates the calcium‐dependent release of excitatory amino acids from depolarized hippocampal slices

  1995cited by this paper
• Expression and role of ionotropic glutamate receptors in pancreatic islet cells

  1995cited by this paper
• Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: a novel systemically active ionotropic glutamate receptor antagonist.

  1995cited by this paper
• Dr. Goff Replies

  1995cited by this paper
• MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles.

  1995cited by this paper
• Effect of NMDA receptor antagonists on prostaglandin E2-induced hyperalgesia in conscious mice.

  1995cited by this paper
• Anticonvulsant activity of a novel NMDA/glycine site antagonist, MDL 104,653, against kindled and sound-induced seizures.

  1995cited by this paper
• Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.

  1995cited by this paper

• Glutaminergic Modulators as Potential Therapeutic Modalities for Neuropathic Pain.

  2025cites this paper
• Cognitive impairments by formaldehyde exposure in Alzheimer's disease

  2024cites this paper
• Astrocyte neuronal metabolic coupling in the anterior cingulate cortex of mice with inflammatory pain.

  2024cites this paper
• NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders

  2024cites this paper
• Exploration of the potential neuroprotective compounds targeting GluN1-GluN2B NMDA receptors

  2023cites this paper
• Design, synthesis and evaluation of novel 1-phenyl-pyrrolo[1,2-b]isoquinolin-3-one derivatives as antagonists for the glycine binding site of the NMDA receptor.

  2023cites this paper
• Selected biochemical mechanisms of lead neurotoxicity

  2023cites this paper
• The Role or NMDA Receptors in Epileptogenesis

  2021cites this paper
• Transition Metal‐Free N‐Arylation of Amino Acid Esters with Diaryliodonium Salts

  2021cites this paper
• Association between Exposure to Components of Pulp and Paper Industry Emissions and Diseases in Children

  2021cites this paper
• Hormetic-Like Effects of L-Homocysteine on Synaptic Structure, Function, and Aβ Aggregation

  2020cites this paper
• Effects of nitrous oxide on glycinergic transmission in rat spinal neurons.

  2020cites this paper
• Nonionotropic Action of Endothelial NMDA Receptors on Blood–Brain Barrier Permeability via Rho/ROCK-Mediated Phosphorylation of Myosin

  2020cites this paper
• Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy

  2020cites this paper
• Targeting Ionotropic Glutamate Receptors In The Treatment Of Epilepsy.

  2020cites this paper
• Negative Correlation Between Serum Levels of Homocysteine and Apolipoprotein M.

  2019cites this paper
• Synaptic Transmission and Amino Acid Neurotransmitters

  2019cites this paper
• GPR17 is an essential regulator for the temporal adaptation of sonic hedgehog signalling in neural tube development

  2019cites this paper
• Comprehensive QSAR studies reveal structural insights into the NR2B subtype selective benzazepine derivatives as N-Methyl- -Aspartate receptor antagonists

  2019cites this paper
• Studies of a novel analgesic identified by establishing a structure-activity relationship for the analgesic prototype, isovaline

  2018cites this paper
• GPR17 is an Essential Component of the Negative Feedback Loop of the Sonic Hedgehog Signalling Pathway in Neural Tube Development

  2018cites this paper
• Neuroprotection and neurotoxicity in the developing brain: an update on the effects of dexmedetomidine and xenon.

  2017cites this paper
• Exploring Quantum Chemical Descriptors and Molecular Docking Approach for Designing Antagonist Search Model for the Glycine/NMDA Receptor Site

  2017cites this paper
• NMDA Receptors as Potential Therapeutic Targets in Diabetic Nephropathy: Increased Renal NMDA Receptor Subunit Expression in Akita Mice and Reduced Nephropathy Following Sustained Treatment With Memantine or MK-801

  2016cites this paper
• Evaluation of the role of N-methyl-D-aspartate (NMDA) receptors in insulin secreting beta-cells.

  2016cites this paper
• Synthesis of 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides and their evaluation as ligands for NMDA receptor glycine binding site

  2016cites this paper
• Protein Structure and Folding

  2016cites this paper
• Molecular Modeling and In Silico Evaluation of Novel Pyridazinones Derivatives as Anticonvulsant Agents

  2015cites this paper
• Neuroprotective activity of creatylglycine ethyl ester fumarate.

  2015cites this paper
• The NMDA receptor functions independently and as an LRP1 co-receptor to promote Schwann cell survival and migration

  2015cites this paper
• Ionotropic glutamate receptor dysfunction in pediatric neurodevelopment

  2015cites this paper
• Investigational therapies for the pharmacological treatment of alcoholism

  2015cites this paper
• Ischemic stroke as a complex polygenic disease

  2015cites this paper
• Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model.

  2014cites this paper
• Novel synthesis of carbohydrate fused α-amino γ-lactams and glycopeptides by NIS mediated ring opening of donor-acceptor substituted cyclopropanes.

  2014cites this paper
• A Facile Diversity-Oriented Multicomponent One-Pot Synthesis of 3-Amino-6,7-dihydrobenzo[c]thiophen-4(5H)-one Derivatives from alpha-Oxo-N,S-ketene Acetal

  2014cites this paper
• Einfluss von Polymorphismen des DAO-Gens auf Schizophrenie und den Endophänotyp Gedächtnisleistung

  2014cites this paper
• Aus der Klinik und Poliklinik für Psychiatrie und Psychotherapie der Ludwig-Maximilians-Universität München

  2013cites this paper
• Dynamic regulation of P-glycoprotein in human brain capillaries.

  2013cites this paper
• Crystal Structure and Pharmacological Characterization of a Novel N-Methyl-d-aspartate (NMDA) Receptor Antagonist at the GluN1 Glycine Binding Site*

  2013cites this paper
• Bimodal effect of D-aspartate on brain aging processes: insights from animal models.

  2013cites this paper
• Molecular Mechanism of a Novel GluN 1 Glycine-Site Antagonist ! " ! ! Crystal Structure and Pharmacological Characterization of a Novel NMDA Receptor Antagonist at the GluN 1 Glycine Binding Site

  2013cites this paper
• Timing-dependent reduction in ethanol sedation and drinking preference by NMDA receptor co-agonist d-serine.

  2012cites this paper
• Predictive QSAR models of 3-acylamino-2-aminopropionic acid derivatives as partial agonists of the glycine site on the NMDA receptor

  2011cites this paper
• Analysis of the enantiomers of serine by reversed-phase high-performance liquid chromatography with OPA-Boc as pre-column derivatization agent. Critical evaluation of the analysis of d-serine in rat brain

  2011cites this paper
• Reference Values for Electrolytes and Blood Gases in Wistar Rats with Permanent Cerebral Ischemia: The Effect of Treatment with Glycine on Gasometry and Electrolytes

  2011cites this paper
• Synthesis, labelling and evaluation of hydantoin-substituted indole carboxylic acids as potential ligands for positron emission tomography imaging of the glycine binding site of the N-methyl-D-aspartate receptor

  2011cites this paper
• New antiepileptic agents: structure–activity relationships

  2011cites this paper
• Searching for Presynaptic NMDA Receptors in the Nucleus Accumbens

  2011cites this paper
• Aus dem Lehrstuhl für Pharmakologie, Toxikologie und Pharmazie des Veterinärwissenschaftlichen Departments der Tierärztlichen

  2010cites this paper
• Dual Allosteric Effect in Glycine/NMDA Receptor Antagonism: A Comparative QSAR Approach

  2010cites this paper
• Molecular structure of ionotropic glutamate receptors.

  2010cites this paper
• Synthesis and evaluation of quinazolinone derivatives as inhibitors of NF-kappaB, AP-1 mediated transcription and eIF-4E mediated translational activation: inhibitors of multi-pathways involve in cancer.

  2010cites this paper
• N-Methyl-d-Aspartate-Induced Oscillatory Properties in Neocortical Pyramidal Neurons From Patients With Epilepsy

  2010cites this paper
• Aaptamine and related products. Their isolation, chemical syntheses, and biological activity.

  2009cites this paper
• Drug design, in vitro pharmacology, and structure-activity relationships of 3-acylamino-2-aminopropionic acid derivatives, a novel class of partial agonists at the glycine site on the N-methyl-D-aspartate (NMDA) receptor complex.

  2009cites this paper
• Activation Mechanisms of the NMDA Receptor

  2009cites this paper
• Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazolines as glycine/N-methyl-D-aspartic acid receptor antagonists.

  2009cites this paper
• Antinociceptive effects of systemic lidocaine: involvement of the spinal glycinergic system.

  2009cites this paper
• NMDA-gated ion channel research and its therapeutic potentials in neurodegenerative diseases: a review

  2009cites this paper
• Antagonists of AMPA/KA and NMDA (glycine site) glutamate receptors

  2008cites this paper
• Taurine increases mitochondrial buffering of calcium: role in neuroprotection

  2008cites this paper
• Taurine increases mitochondrial buffering of calcium: role in neuroprotection

  2008cites this paper
• Antiepileptika – Wirkprinzipien und strukturelle Parameter. Wissenswertes zur Pharmakokinetik und Pharmakodynamik

  2007cites this paper
• [Antiepileptics--action principles and structural parameters].

  2007cites this paper
• Direct Correlation Between Ischemic Injury and Extracellular Glycine Concentration in Mice With Genetically Altered Activities of the Glycine Cleavage Multienzyme System

  2007cites this paper
• Amino acid transmitters

  2007cites this paper
• The pharmacokinetics and neuropharmacological action of the new antiepileptic drugs vigabatrin and levetiracetam

  2007cites this paper
• Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies.

  2006cites this paper
• Competitive Gly/NMDA receptor antagonists.

  2006cites this paper
• Glycine/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA-1021 and related compounds.

  2006cites this paper
• Tricyclic quinoxalinediones, aza-kynurenic acids, and indole-2-carboxylic acids as in vivo active NMDA-glycine antagonists.

  2006cites this paper
• Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptor.

  2006cites this paper
• RVLM glycine receptors mediate GABAA and GABAB)independent sympathoinhibition from CVLM in rats.

  2006cites this paper
• Role of altered structure and function of NMDA receptors in development of alcohol dependence.

  2005cites this paper
• New anticonvulsant agents.

  2005cites this paper
• Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion.

  2005cites this paper
• Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.

  2005cites this paper
• Novel pyrrolinones as N-methyl-D-aspartate receptor antagonists.

  2005cites this paper
• 3-hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists.

  2004cites this paper
• Antagonists and Agonists at the Glycine Site of the NMDA Receptor for Therapeutic Interventions

  2003cites this paper